Company news
Botanix Pharmaceuticals Limited news in 2020
Botanix Pharmaceuticals Limited's news releases, calls and decks from 2020, newest first.
Update on BTX 1801 Phase 2a Clinical Study
December 13, 2020
FDA Clears Development Path for BTX 1801
November 10, 2020
Response to ASX Price Query
September 29, 2020
New Antimicrobial Data and Conference Presentation
September 7, 2020
Appendix 4E and Annual Report to Shareholders
August 31, 2020
BTX 1801 Phase 2a Antimicrobial Study Underway
August 11, 2020
Response to ASX Aware Query
July 22, 2020
BTX 1503 End of Phase 2 Milestone with FDA
July 16, 2020
FDA Grants BTX 1801 QIDP Designation Status
April 23, 2020
Botanix Provides Update on Development Activities Amended
April 16, 2020
Botanix Provides Update on Development Activities
April 15, 2020
Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data
March 24, 2020
Antimicrobial Platform Update and Launch of BTX 1801 Study
March 12, 2020
Decks in 2020
- Shareholder Meeting (November 2020)
Shareholder meeting · 21 slides · Nov 23, 2020
- 2020 ASX Small & Mid-Cap Virtual Conference
Conference · 20 slides · Sep 8, 2020